Related by context. All words. (Click for frequent words.) 68 torezolid phosphate 68 oral methylnaltrexone 67 bardoxolone 67 CEQ# 67 Alzhemed TM 66 pradefovir 66 forodesine 66 Pafuramidine 66 elotuzumab 65 Allovectin 7 R 65 NEUMUNE 65 Diamyd ® 65 MAXY alpha 65 Allovectin 7 65 MAXY G# 65 ChimeriVax JE 65 faropenem 65 Prosaptide 64 YONDELIS 64 Phase 2a clinical trials 64 Phase Ib study 64 Phase IIb clinical trials 64 Fx #A 64 Surfaxin LS 64 rilonacept 64 elvucitabine 64 oral talactoferrin 64 oral antiviral 64 vidofludimus 64 MAGE A3 ASCI 64 Dacogen injection 64 Fibrillex TM 64 HQK 64 Altastaph 64 mertansine 64 Plicera 64 Stimuvax R 64 Allovectin 7 ® 64 R#/MEM # 64 subcutaneous formulation 63 PHX# 63 nonclinical studies 63 CRMD# 63 TRO# 63 Phase IIIb clinical 63 ocrelizumab 63 Amigal 63 Fodosine 63 PDE4 inhibitor 63 eniluracil 63 lomitapide 63 RhuDex ® 63 HuMax EGFr 63 DermaVir Patch 63 oral prodrug 63 Protexia R 63 NP2 Enkephalin 63 oxymorphone ER 63 Egrifta 63 inhaled AAT 63 Phase #b/#a 63 midstage clinical 63 rPA anthrax vaccine 63 Dr. McHutchison 63 HCD# [002] 63 ganaxolone 63 telaprevir VX 63 non nucleoside 63 Protexia ® 63 CDP# 63 SAR# [004] 63 VIR# 63 riociguat 63 GED aPC 63 Maribavir 63 danoprevir 63 OHR/AVR# 63 phase IIa clinical 63 Aurexis 63 ELACYT 63 Pimavanserin 63 Hedgehog antagonist 63 successfully commercialize Iluvien 62 APTIVUS 62 SNT MC# 62 Bicifadine 62 Valortim ® 62 TransVax ™ 62 OvaRex ® MAb 62 GAMMAGARD 62 ASONEP 62 CINTREDEKIN BESUDOTOX 62 TPI ASM8 62 Anthim 62 forodesine hydrochloride 62 Diamyd R 62 neratinib 62 IMA# 62 Phase IIb III 62 Civacir 62 Archexin 62 SUTENT ® 62 Aviptadil 62 Immunotherapeutic 62 Phase #/#a 62 apricitabine ATC 62 Thiovir 62 NOX E# 62 Panzem R NCD 62 Phenoptin 62 CCR5 antagonist 62 apricitabine 62 Shigamabs ® 62 Phase Ia 62 orBec 62 tolevamer 62 crofelemer 62 Zemplar Capsules 62 Xanafide 62 intranasal formulation 62 Traficet EN 62 Valortim 62 phase Ib 62 Insegia 62 alvespimycin 62 CCR5 mAb 62 Tarceva TM 62 UVIDEM 62 tolerability profiles 62 GLP toxicology studies 62 JAK inhibitor 62 drug ISA# 62 Kosan dependence 62 Zerenex 62 Phase Ib clinical 62 talactoferrin 62 HuMax CD4 62 MGN# 62 phase IIb 62 tramiprosate ALZHEMED TM 62 CCR5 inhibitor 62 Phase 1a clinical 62 dexanabinol 61 SinuNase TM 61 stated Michelle Berrey 61 Proquin XR 61 eprotirome 61 SILENOR TM 61 indibulin 61 investigational hepatitis B 61 IND submission 61 SinuNase ™ 61 Evoltra ® 61 trastuzumab DM1 61 UPLYSO 61 CRLX# 61 BENLYSTA ® 61 Prodarsan ® 61 LEVADEX ™ 61 DPX Survivac 61 methylnaltrexone 61 Guanilib 61 #D#C# 61 DB# [003] 61 velafermin 61 maximally tolerated dose 61 ritonavir boosted danoprevir 61 Pruvel 61 RSD# oral 61 PRT# 61 trastuzumab DM1 T DM1 61 EGRIFTA TM 61 ROTATEQ 61 ALN PCS 61 lucinactant 61 generation purine nucleoside 61 dacetuzumab 61 Prednisporin TM 61 CMV vaccine 61 Virulizin ® 61 Oglemilast 61 BioNumerik 61 tramiprosate Alzhemed TM 61 urocortin 2 61 atacicept 61 BLA filing 61 oral deforolimus 61 Aclidinium 61 obatoclax 61 VivaGel TM 61 XL# XL# XL# XL# 61 custirsen 61 Tavocept 61 zanolimumab 61 INCB# [001] 61 CAELYX 61 liprotamase 61 PREOS 61 oral PTH 61 ospemifene 61 Acute Radiation Syndrome ARS 61 DEB# 61 albinterferon alfa 2b 61 EOquin TM 61 Aryplase 61 pafuramidine maleate 61 ruxolitinib 61 Canvaxin 61 Lupuzor 61 celgosivir 61 Onalta 61 antibody MAb 61 HepeX B 61 ATL# [001] 61 tanespimycin 61 Spiegelmer ® 61 refractory gout 61 KNS # 61 MyVax ® 61 Cloretazine ® 61 THALOMID 61 triphendiol 61 VitiGam TM 61 Solulin 61 acyclovir Lauriad R 60 Phase 2b clinical trials 60 Pyridorin 60 refractory CLL 60 Anturol TM 60 Phase Ib II 60 Cloretazine R VNP#M 60 teduglutide 60 LibiGel ® 60 oral salmon calcitonin 60 inecalcitol 60 HuMax TAC 60 Prestara 60 preclinical efficacy 60 Zavesca R 60 Voraxaze 60 Onconase 60 clevudine 60 teplizumab 60 Canvaxin TM 60 Noxafil 60 elacytarabine 60 non nucleoside HCV 60 EndoTAG TM -1 60 fostamatinib 60 Troxatyl 60 midstage trials 60 cannabinor 60 Darinaparsin 60 nitazoxanide 60 TYZEKA 60 ALN TTR# 60 Clonicel 60 Factor VIIa 60 CELVAPAN H#N# 60 nucleotide analog 60 NEBIDO 60 Saforis 60 chemotherapy induced neutropenia 60 SCIB1 60 Valortim R 60 Phase IIb trials 60 DCCR 60 dirucotide MBP# 60 Dextofisopam 60 GALNS 60 vosaroxin 60 chronic HCV infection 60 TransVax tm 60 systemically administered 60 Azedra 60 FluINsure 60 Corlux 60 CCX# 60 HCV polymerase 60 Phase Ib 60 PXD# 60 PGL# 60 ALN RSV program 60 interferon gamma 1b 60 afamelanotide 60 tipifarnib 60 Mycograb 60 therapeutic monoclonal antibody 60 ARIKACE ™ 60 EOquin 60 PrevOnco 60 non nucleoside inhibitor 60 GRNVAC1 60 CTAP# Capsules 60 Urocidin TM 60 personalized immunotherapy 60 BrachySil TM 60 LGLS 60 Phase 2a trial 60 zileuton CR 60 efalizumab 60 radezolid 60 HIV coinfected 60 Removab 60 HIV integrase inhibitor 60 pharmacokinetics pharmacodynamics 60 ZADAXIN ® 60 incyclinide 60 docetaxel Taxotere ® 60 initiate Phase IIa 60 adecatumumab MT# 60 IRX 2 60 CCR5 receptor antagonist 60 subcutaneous PRO 60 TransVax TM 60 pharmacokinetic PK study 60 Tasimelteon 60 Sym# 60 ZK EPO 60 dirucotide 60 paromomycin 60 rALLy trial 60 CCR5 inhibitors 60 HEPLISAV ™ 60 relapsed MM 60 Hyphanox 60 immunotherapeutic vaccine 60 Sebivo 60 acetonide FA 60 Clevudine 60 CBLC# 60 Preclinical studies suggest 60 Diamyd r 60 rindopepimut 60 Mipomersen 60 MBP# [001] 60 investigational therapies 60 OVATURE 60 Cerashield 60 CONBRIZA 60 DDP# 60 CR# vcMMAE 60 PD LID 60 Medidur FA 60 cilengitide 60 CytoFab 60 baminercept 60 Annamycin 60 oral taxane 60 Cancidas 60 Onalta ™ 60 Phase 1a 60 volociximab 60 Veronate 60 TLR9 agonist 60 otelixizumab 60 eprodisate Fibrillex TM 60 GSK# [002] 60 aflibercept 60 #I TM# 60 preclinically 60 Aganocide 60 Velcade bortezomib 60 Restanza 60 SILENOR ™ 60 nucleoside analog 60 PEG PAL 60 ATryn ® 59 PDE# inhibitors 59 pharmacokinetic PK profile 59 ATryn R 59 phase IIa 59 nalbuphine ER 59 GSK# [001] 59 omecamtiv mecarbil 59 Japanese Encephalitis Vaccine 59 Evoltra TM 59 TOCOSOL Paclitaxel 59 AVP #D# 59 NeuVax 59 PRTX 59 AEG# 59 TBC# 59 Evoltra 59 ATL/TV# 59 PrevOnco ™ 59 velafermin belinostat 59 Aptivus ® 59 anti CD3 monoclonal 59 PREOS R 59 Anidulafungin 59 OvaRex R 59 ATL# [002] 59 PentaStaph 59 PSN# [002] 59 BARACLUDE R 59 Rescula 59 Gelclair R 59 novel VDA molecule 59 pharmacokinetic studies 59 TELINTRA 59 Plenaxis TM 59 regorafenib 59 Bezielle 59 BAL# [002] 59 Solasia 59 FluCide 59 Simulect 59 selective S#P# receptor agonist 59 Actilon 59 ISTODAX 59 tivozanib 59 CINOD 59 Japanese Encephalitis vaccine 59 Arranon 59 ganetespib 59 HGS# 59 PANVAC VF 59 GLPG# 59 OncoGel 59 BEXXAR 59 EGS# 59 Daclizumab 59 tubulin inhibitor 59 Frova ® 59 HuLuc# 59 MAXY VII 59 Asentar 59 synthetic retinoid 59 eosinophilic asthma 59 Aptivus 59 Octreolin 59 BEMA Granisetron 59 luliconazole 59 LAS# [002] 59 epigenetic therapies 59 Cimzia TM 59 ONCONASE R 59 valopicitabine 59 Zavesca r 59 octreotide implant 59 Plenaxis R 59 ridaforolimus 59 RIGScan CR 59 Triolex 59 omiganan 59 BLA submission 59 Panzem R 59 mebendazole 59 BRAF V# mutation 59 FOLOTYN ® 59 Allovectin 7 r 59 phase IIb study 59 Benlysta belimumab 59 alemtuzumab MS 59 daptomycin 59 PROCHYMAL 59 ALN TTR 59 BioVant 59 JAK3 inhibitor 59 Alinia 59 FACTIVE tablets 59 TH# [003] 59 dose cohort 59 Phase IIB 59 TLK# 59 Androxal TM 59 proteasome inhibitor 59 aerosolized AAT 59 TKM ApoB 59 WILEX 59 LymphoStat B TM 59 Forodesine HCl 59 Eniluracil 59 Uvidem 59 omacetaxine mepesuccinate 59 Neurodex 59 KIACTA ™ 59 budesonide foam 59 Triapine 59 tremelimumab 59 squalamine 59 Exelixis compounds 59 Pazopanib 59 RiVax 59 TRISENOX 59 Alvesco R 59 inhalation powder 59 Soliris TM eculizumab 59 H#N# VLP vaccine 59 JAK2 inhibitor 59 Genz # 59 Cloretazine 59 Teflaro 59 Cytolin 59 amifampridine phosphate 59 orphan medicinal product 59 Telintra 59 Cinryze ™ 59 NovaBay Aganocide compounds 59 SEBIVO 59 ularitide 59 casopitant 59 Viramidine 59 Glufosfamide 59 Vacc 4x 59 AQ4N 59 PEG Interferon lambda 59 INTEGRILIN R eptifibatide Injection 59 ISIS # 59 Cytolin ® 59 TRIOLEX 59 nanoviricides 59 LEP ETU 59 registrational 59 ORENCIA R 59 PEG SN# 59 URG# 59 preclinical toxicology 59 HCV polymerase inhibitor 59 seasonal influenza VLP vaccine 59 TACI Ig 59 Zerenex ™ 59 Triapine R 59 Aplidin 59 ACOMPLIA R 59 GLP toxicology 59 Ceflatonin 59 laninamivir 59 Telatinib 59 IDX# 59 Argatroban 59 RGB # 59 Aurograb 59 pharmacodynamic PD 59 RLY# 59 Cinquil 59 Cethromycin 59 NICOSAN TM 59 diabetic neuropathic pain 59 phase IIb trial 59 Prodarsan 59 pharmacokinetic pharmacodynamic 59 novel oral anticoagulant 58 amrubicin 58 Phase #b/#a trial 58 ZFP Therapeutic 58 small molecule Hedgehog 58 Bioral Amphotericin B 58 nucleotide analogue 58 RiVax ™ 58 miconazole Lauriad ® 58 cystinosis patients 58 Actimmune ® 58 BIM #A# 58 Chimigen TM 58 valent pneumococcal conjugate vaccine 58 Phase IIa clinical trials 58 Increlex TM 58 Loramyc 58 Phase IIa clinical 58 Phase 2b trial 58 HGS ETR2 58 galiximab 58 Fast Track Status 58 Elocalcitol 58 aclidinium bromide 58 Martin Nicklasson CEO 58 Icatibant 58 samalizumab 58 Poly ICLC 58 Symadex 58 AZILECT R 58 reslizumab 58 aleglitazar 58 virus HCV 58 Harry Palmin President 58 Behcet uveitis 58 Dalbavancin 58 IV APAP 58 optimal dosing regimens 58 XL# XL# 58 Blinatumomab 58 pain palliation 58 SILENOR 58 posaconazole 58 Itopride 58 HCV protease inhibitors 58 registrational trial 58 OncoVEX GM CSF 58 Afatinib 58 Valtropin 58 glucokinase activator 58 Lumacan 58 blinatumomab 58 Cetrorelix 58 Pegasys plus Copegus 58 GLASSIA 58 Testosterone MDTS ® 58 rhThrombin 58 TRIST study 58 Bioral 58 Phase III LibiGel 58 AZILECT ® 58 SYCREST 58 isavuconazole 58 Dacogen decitabine 58 IL# PE#QQR 58 cathepsin K inhibitor 58 POSIDUR TM 58 canakinumab 58 pitavastatin 58 romidepsin 58 Cethrin 58 huC# DM4 58 romiplostim 58 pharmacokinetics PK 58 refractory APL 58 cMET inhibitor 58 entity NCE 58 Raptiva R 58 ROTARIX 58 anticancer compound 58 Nexavar sorafenib 58 polymerase inhibitor 58 CTA# 58 TOLAMBA 58 Exelixis XL# 58 Flutiform TM 58 oral ridaforolimus 58 RNAi therapeutic targeting PCSK9 58 Kamada AAT 58 Aurora kinase inhibitor 58 oral RSD# 58 SPRIX ® 58 indiplon capsules 58 lorvotuzumab mertansine 58 taribavirin 58 ELIQUIS 58 Teysuno 58 outlicensed 58 GeoVax vaccine 58 tasimelteon 58 Anavex #-# 58 AKT inhibitor 58 Iluvien ® 58 EndoTAG TM 58 pharmacodynamic properties 58 Oasmia 58 Maxy G# 58 severe hypercholesterolemia 58 Syncria 58 REGN# 58 Quinamed 58 ELND# 58 lintuzumab SGN 58 senicapoc 58 Phase IIa trials 58 cariprazine 58 Increlex R 58 ACAPODENE TM 58 Dynepo 58 Elvitegravir 58 Urocidin 58 oxypurinol 58 HCV antiviral 58 Personalized Immunotherapy 58 Desmoteplase 58 pomalidomide 58 Zenpep 58 integrase inhibitor 58 ATG Fresenius S 58 dose escalation phase 58 cancer neuroendocrine tumor 58 novel therapeutic antibodies 58 Cleviprex TM clevidipine 58 RAPTIVA 58 AIMM trial 58 OMP #M# 58 relapsed multiple myeloma 58 VivaGel R 58 Cytolin R 58 Initiates Clinical 58 tamibarotene 58 Cloretazine R 58 Phase 2b study 58 maribavir 58 bicifadine 58 L BLP# 58 KRN# 58 telomerase therapeutic 58 blood clot dissolver 58 Tripep 58 APTIVUS ritonavir 58 MAA submission 58 CANCIDAS 58 teriflunomide 58 prostone 58 octreotide acetate 58 Cimzia R 58 zileuton IV 58 pharmacodynamic parameters 58 axitinib 58 Amrubicin 58 ImmunoGen TAP technology 58 mipomersen 58 PNT# 58 IMVAMUNE R 58 ataluren 58 opioid bowel dysfunction 58 StemEx R 58 Voraxaze ™ 58 Recombinant interferon alpha 58 sodium stibogluconate 58 CIP ISOTRETINOIN 58 thymalfasin 58 personalized dendritic cell 58 PROVENGE sipuleucel T 58 immune modulating 58 MEK Inhibitor 58 INS# [001] 58 vilazodone 58 generation NNRTI 58 CYT# potent vascular disrupting 58 trivalent influenza vaccine 58 Vernakalant 58 balsalazide tablet 58 Rotarix ® 58 phase Ib clinical 58 GTC recombinant human 58 Inhaled AAT 58 photoprotective drug 58 SinuNase 58 NEUGENE antisense 58 LymphoStat B belimumab 58 multidose 58 Somatuline Depot 58 Nicole Onetto MD 58 rNAPc2 58 treatment naive genotype 58 vismodegib 58 immunotherapeutic approaches 58 HuMax CD# 58 Retacrit 58 CD# CEA 58 histamine dihydrochloride 58 TASKi3 58 RhuDex R 58 TEMODAL 58 EDEMA3 trial 58 Tamibarotene 58 phase 2a 58 Vicriviroc 58 Albugon 58 aplindore 58 Iluvien TM 58 Vidaza azacitidine 58 Trovax 58 SUVN 58 Prodarsan R 58 Q#IR 58 CVac 58 evaluating tivozanib 58 Linjeta TM 58 omega interferon 58 Genasense ® 58 lumiliximab 58 Onrigin 58 AnGes 58 thorough QT 58 Zenvia ™ 58 pexiganan 58 MORAb 58 Elacytarabine 58 ZYBRESTAT fosbretabulin 58 Fabry Disease 58 RenaZorb TM 58 R sorafenib tablets 58 XL# SAR# 58 hepatitis C HCV 58 rFIXFc 58 panitumumab Vectibix 58 Rotarix R 58 Zavesca ® 58 ulimorelin 58 HspE7 58 PLK1 SNALP 58 Preotact 58 AMD# [003] 58 CINQUIL 58 ancrod 58 Phase 1b 58 mGluR5 NAM 58 VEGF Trap 58 huN# DM1 58 novel peptides 58 LibiGel ® testosterone gel 58 CaPre TM 57 Lixivaptan 57 Neuradiab 57 OMAPRO 57 Zoraxel 57 Medidur TM FA 57 Trofex 57 investigational humanized monoclonal antibody 57 CIMZIA ™ 57 phase IIb III 57 Kepivance 57 RELOVAIR ™ 57 oral cladribine 57 SCOLR Pharma 57 ritonavir boosting 57 romazarit 57 NeuroSTAT ® 57 Clavis Pharma 57 protease inhibitor PI 57 oral rivaroxaban 57 Aerosurf 57 cMET 57 pegylated interferons 57 confirmatory Phase III 57 Novartis NVS Snapshot Report 57 faropenem medoxomil 57 PF # [001] 57 DepoVax ™ vaccine 57 tramiprosate 57 Raptiva ® 57 CRD5 57 Nanobody R 57 Crofelemer 57 Fresenius Biotech 57 bortezomib Velcade 57 P#X# antagonist 57 Menerba 57 ritonavir boosted protease inhibitor 57 HDL Selective Delipidation 57 Solazed 57 Liprotamase 57 Omigard 57 Aganocide ® 57 PROSTVAC TM 57 tiapamil 57 virus HCV protease inhibitor 57 IGN# 57 Tesmilifene 57 selective orally bioavailable 57 Apaziquone 57 StaphVAX R 57 JOULFERON 57 Squalamine 57 APTIVUS r 57 TMC# [002] 57 dose escalation clinical 57 eltrombopag 57 Tech DVAX 57 favorable pharmacokinetic profile 57 investigational hepatitis C 57 OMNARIS HFA 57 TYGACIL 57 Kyowa Kirin 57 eritoran 57 SUMAVEL DosePro 57 prasterone 57 rhC1INH 57 EVIZON TM 57 Bronchitol 57 lixivaptan 57 Multimeric 57 MGd 57 multicenter Phase II 57 palifermin 57 OncoVEX 57 BioOne Corporation 57 Arikace 57 sorafenib tablets 57 INTERCEPT platelets 57 randomized Phase 2b 57 DXL# 57 dalbavancin 57 Chemophase 57 EP #R 57 Phase IIA 57 basal insulin analogue 57 Hematide ™ peginesatide 57 glufosfamide 57 ketolide antibiotic 57 recurrent glioblastoma multiforme 57 LHRH antagonist 57 HBV vaccine 57 Theratope 57 Loramyc ™ 57 alvimopan 57 Pancreas Cancer Vaccine 57 Somatuline R Autogel R 57 Entereg TM 57 almorexant 57 PROMACTA 57 Cardio Vascu Grow 57 TOCOSOL Camptothecin 57 chronic HBV 57 sargramostim 57 ceftazidime 57 MyVax personalized immunotherapy 57 MoxDuo IR 57 eTag assays 57 InterfeRx 57 Initiates Phase III 57 Potelligent Technology 57 Elisabeth Lindner CEO 57 bifeprunox 57 Neulasta ® 57 hoFH 57 depsipeptide 57 MOZOBIL 57 phase IIb clinical 57 GATTEX TM 57 polymerase inhibitors 57 TRX1 57 Novolimus 57 Ketotransdel 57 anticoagulant reversing agent 57 Virulizin R 57 resminostat 57 sitaxsentan 57 prucalopride 57 AERx iDMS 57 TKB# 57 oral mTOR inhibitor 57 TKM Ebola 57 AMEVIVE 57 JNJ Q2 57 Firazyr 57 MEK inhibitor 57 PI3K/Akt pathway inhibitor 57 CAMPATH 57 INTELENCE 57 lurasidone 57 BAY #-# 57 EndoTAGTM 1 57 safety tolerability pharmacokinetic 57 thrombin inhibiting aptamer 57 IND enabling 57 USL# 57 ONTAK 57 CIMZIA TM 57 Nitazoxanide 57 Hepatitis C HCV 57 pharmacodynamic markers 57 lanthanum carbonate 57 AzaSite Plus 57 microtubule inhibitor 57 miglustat 57 cinacalcet HCl 57 rolapitant 57 Joulferon 57 isoform selective 57 virus HCV infection 57 IAP inhibitors 57 Proellex TM 57 Trimesta 57 ocular formulation 57 cellulose sulfate 57 briakinumab 57 pharmacokinetic PK 57 RhuDex 57 fipamezole 57 RNAi therapeutic targeting 57 pDNA vaccine 57 NUVIGIL 57 preclinical pharmacokinetic 57 aerosolized KL4 surfactant 57 Clolar ® 57 Heplisav 57 TroVax ® 57 visilizumab 57 Ixiaro 57 oral FTY# 57 erythropoietic 57 torezolid 57 Factor Xa inhibitor 57 SEPET TM 57 ZFP Therapeutics 57 terlipressin 57 anagrelide 57 LAB CGRP 57 alkylating agent 57 SynCon 57 VP# [004] 57 PhG alpha 1 57 anti JCV antibody 57 iclaprim 57 Panzem 57 Laquinimod 57 intravenous formulations 57 orBec R 57 DU #b 57 Initiate Phase 57 severe oral mucositis 57 tezampanel NGX#